Drug & supplement interaction

Chirata + Mogamulizumab-kpkc

Mogamulizumab-kpkc brand name: Poteligeo.

No Known Interaction
Medically reviewed by · Updated June 2026 · Pair last verified Sep 13, 2026
The bottom line No known interaction

We found no known interaction between Chirata and Mogamulizumab-kpkc in our sources. Absence of a documented interaction is not the same as proven safety, and does not guarantee one does not exist. Do not start, stop, or change a medication or supplement based on this page; confirm with your pharmacist or doctor first.

Know someone taking this? Share
Facebook Post Reddit Email
On this page
Interaction report

Chirata and Mogamulizumab-kpkc

We checked these two against our interaction database. Here is what we found.

No Known Interaction Found

We did not find a documented interaction between Mogamulizumab-kpkc and Chirata in our sources. This does not guarantee that the combination is completely free of risk — there is often limited research on supplements and herbal products, especially around drug interactions.

If you decide to take both, the practical routine is simple: add one new thing at a time and note the date you started it. If the combination is going to disagree with you, it usually shows in the first days to a couple of weeks — and a start date turns “I’ve been feeling off” into something a pharmacist can actually work with. Do not stop a prescribed medicine on your own.

Always talk with your pharmacist or doctor before making changes to your medications or supplements, particularly if you take several medications or have an ongoing health condition.

Chirata safety at a glance

Chirata overall Use caution Generally used in small amounts in traditional medicine, but human safety data are limited.
Pregnancy Avoid Not enough safety data; avoid use during pregnancy.
Breastfeeding Avoid Not enough safety data; avoid use while breastfeeding.

Safety guidance is general; always confirm with your pharmacist or doctor for your situation.

Still wondering about combining Mogamulizumab-kpkc and Chirata? Ask Dr. Brian Staiger, PharmD, BCPS directly ›
Keep it in perspective

Chirata Does Interact With Other Medications

Chirata has 86 moderate known drug interactions in our database — Mogamulizumab-kpkc isn’t one of them. If you take anything else, check it against the full list below.

Moderate 86 No known interaction 2,744 (incl. Mogamulizumab-kpkc)
Taking anything else?

Check Another of Your Medications Against Chirata

Covers the 2,830 medications we’ve checked against Chirata. Pick one to open its full report.

What to actually watch for

What Mogamulizumab-kpkc’s Own FDA Label Lists

This is not an interaction — none of it involves Chirata. These are the most notable effects listed in the ADVERSE REACTIONS section of Mogamulizumab-kpkc’s own FDA label, for the medication by itself. Knowing the drug’s own list makes it easier to work out the likely cause if something new turns up while you take both. 6 of them are worth acting on rather than waiting out — marked below.

  • Chest pain Worth acting on
  • A low platelet count Worth acting on
  • Anemia Worth acting on
  • Raised blood pressure Worth acting on
  • Liver problems Worth acting on
  • A higher chance of infection Worth acting on
  • Pain in an arm or leg
  • Mouth irritation or sores
  • A skin rash mentioned in 20.1% of FDA reports for Mogamulizumab-kpkc
  • A stuffy or runny nose

Showing the 10 most notable of 21 label-listed effects — ranked by how unusual each one is across medicines generally, with serious effects weighted up.

From the ADVERSE REACTIONS section of the FDA label for Mogamulizumab-kpkc. Read the label on DailyMed › Where a percentage is shown, it is the share of 1,316 voluntary FDA FAERS reports for Mogamulizumab-kpkc that mention that effect — a reporting proportion, not an incidence rate and not evidence the drug caused it. Chirata’s licensed record lists no adverse effects our clinical vocabulary could match, so there is no Chirata side to compare — that is a limit of the record, not a statement that Chirata has no side effects.

Overlapping uses

What Mogamulizumab-kpkc Is Prescribed For, and What Chirata Has Been Studied For

These two come up together because they touch the same health topic — not because they do the same job. Mogamulizumab-kpkc is a prescription medicine with approved uses on its FDA label. Chirata is a supplement: what follows is what researchers have looked at it for, and how strong that evidence is.

Mogamulizumab-kpkc is prescribed for: Poteligeo (mogamulizumab-kpkc), given as an intravenous infusion, is approved to treat adults with relapsed or refractory mycosis fungoides (MF) or Sézary syndrome (SS) — two types of T-cell lymphoma that primarily affect the skin. "Relapsed or refractory" means the cancer has come back or stopped responding to prior treatment. Poteligeo is used only after at least one prior systemic (whole-body) therapy has already been tried.

Chirata has been studied for:

  • Cancer studied, not established Chirata has been studied for this. Natural Medicines rates the evidence: Insufficient Reliable Evidence To Rate Read what the research shows

    Chirata for cancer

    Although there has been interest in using oral chirata for cancer, there is insufficient reliable information about the clinical effects of chirata for this purpose.

Effectiveness ratings and the research summaries above are the verbatim record from the Natural Medicines database, which grades evidence from “Effective” down to “Insufficient Reliable Evidence To Rate”. A rating below the top of that scale means researchers have looked at it — not that it works, and never that it can stand in for a prescribed medicine. Do not stop or replace Mogamulizumab-kpkc on your own; if you are taking Chirata for the same health topic, tell your prescriber, especially if the medicine is being adjusted to a target.

One more smart check

Taking Chirata as Part of a Dietary Supplement Product? Check It for Interactions

We hold 26 real supplement products containing Chirata, each one broken down to its full ingredient list — and combination products often carry several ingredients besides Chirata. Even though Chirata itself has no known interaction with Mogamulizumab-kpkc, another ingredient on your label might. Find your product and we’ll check every ingredient on its label:

How much people look this up

Where Chirata and Mogamulizumab-kpkc Sit Against Everything Else

Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.

Supplement Chirata
Steady interest

#1,239 of 1,452 supplements looked up here in the last 7 days

29 days ago today
Medication Mogamulizumab-kpkc
Top half

#1,201 of 2,830 medications looked up here in the last 7 days

29 days ago today

Position among everything looked up on this site, not a measure of how commonly either one is used or how important it is. A supplement can climb this list because of a news story. It counts every request to the page, automated ones included, and nothing here identifies anyone.

Where does our data come from?
  • Source: the Natural Medicines (TRC Healthcare) clinical database — the evidence-graded professional reference for herb & supplement interactions.
  • Citation library: 103,510 references behind our interaction content, 65,311 of them resolved to verified PubMed/DOI sources. See every Chirata reference on this page ↓
  • Freshness: we automatically re-check this combination every week — this pair was last verified September 13, 2026. The Chirata and Mogamulizumab-kpkc records this page draws on were last updated June 22, 2026.
  • What “no known interaction” means: no documented interaction in the sources above — not a guarantee of safety. Supplements are studied far less than prescription drugs, so we say exactly what the evidence supports, and nothing more.
Data structure & sourcing designed and verified by .
Supplement

About Chirata

What is Chirata?

  • Digestive upset and loss of appetite
  • Fever
  • Blood sugar support
  • Liver health support
  • Skin conditions
  • General 'blood purifier' or tonic

Chirata is a very bitter herb used in traditional Ayurvedic and South Asian medicine, mainly for digestion, fever, and as a general tonic. Human evidence for its benefits is limited, so it should not replace proven treatments, and you should talk to a pharmacist or doctor before using it.

Swertia chirayita · Gentianaceae · Whole plant, especially the dried stems and leaves · Powder, capsules, tablets, water infusion (cold or hot), liquid extract, and traditional herbal blends

An interaction check asks whether these two react with each other — it does not ask whether Chirata is a good idea for someone in your situation. Here is what our Chirata record says about it on its own.

Chirata: dosing

There is no well-established, standardized dose for chirata. The right amount can depend on the form (powder, capsule, or infusion) and the strength of the product.The safest approach is to follow the directions on the product label and not exceed the recommended amount.

From our Chirata monograph — the full record covers uses, side effects and every documented interaction.

Read the full Chirata monograph & all interactions
Medication

About Mogamulizumab-kpkc Injection

What Is Mogamulizumab-kpkc Injection Used For?

Brand name: Poteligeo

Poteligeo (mogamulizumab-kpkc), given as an intravenous infusion, is approved to treat adults with relapsed or refractory mycosis fungoides (MF) or Sézary syndrome (SS) — two types of T-cell lymphoma that primarily affect the skin. "Relapsed or refractory" means the cancer has come back or stopped responding to prior treatment.

Poteligeo is used only after at least one prior systemic (whole-body) therapy has already been tried.

Most-Reported Side Effects for Mogamulizumab-kpkc

From FAERS, the FDA’s public side-effect reporting system (1,316 reports, all brands). Reports are voluntary and are not proof the drug caused the effect.

Rash 188 reports
Disease progression 119 reports
Drug eruption 77 reports
Pruritus 67 reports
Infusion related reaction 57 reports
See full Mogamulizumab-kpkc Injection drug information
Keep checking

Other Drugs & Chirata

Browse every other medication we’ve checked against Chirata — both the ones with a known interaction and the ones without. Select any drug for the full detail.

0Major
86Moderate
0Minor
2,743No known interaction
86 Moderate 2,743 No interaction
Moderate

86 interactions

Showing 60 of 86 moderate interactions — see all 86 on the Chirata page.

No interaction 2,743 drugs checked — show the list

We also checked Chirata against these medications and found no known interaction in our sources. Open any page to confirm.

Showing the 60 most looked-up of 2,743 medications checked with no known interaction — see the full Chirata list.

See the full Chirata interactions page
See every supplement checked against Mogamulizumab-kpkc, ranked by severity
Evidence & sources

Chirata References

The 1 references that drive our Chirata monograph and interaction data, from the evidence-graded Natural Medicines (TRC Healthcare) database. Citations with a link open the study on PubMed or the publisher’s site.

  1. Sekar, B. C., Mukherjee, B., Chakravarti, R. B., and Mukherjee, S. K. Effect of different fractions of Swertia chirayita on the blood sugar level of albino rats. J.Ethnopharmacol. 1987;21(2):175-181. PubMed

Medication overviews come from MedlinePlus (NIH); supplement label data from the NIH Dietary Supplement Label Database. Content is written and reviewed by licensed HelloPharmacist pharmacists — see our data sources and editorial standards.

Pharmacist Counseling Corner

Taking Chirata and Mogamulizumab-kpkc Together: Common Questions

Is it safe to take Chirata with Mogamulizumab-kpkc?
We do not list a known interaction between Chirata and Mogamulizumab-kpkc. That does not guarantee the combination is risk-free, so confirm with your pharmacist or doctor — especially if you take other medications or have a health condition.
Are Chirata and Mogamulizumab-kpkc used for the same thing?
They overlap in purpose, which usually means the real question is whether you need both rather than whether they are safe together. This page lists the shared uses and how strong the evidence is for Chirata in each. That is a conversation for your prescriber, especially if Mogamulizumab-kpkc is being adjusted to a target.
Does Chirata interact with any other medications?
Yes. Chirata has 86 documented drug interactions in our database — Mogamulizumab-kpkc is simply not one of them. If you take anything else, it is worth checking each one; they are all listed on this page.

Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy

Where next

Keep Exploring

Chirata monograph Uses, safety profile, and every drug interaction in one place Mogamulizumab-kpkc Injection drug information The full plain-English guide to this medication Mogamulizumab-kpkc supplement interactions Every supplement checked against Mogamulizumab-kpkc, ranked by severity Supplement interaction checker Check any supplement or product against your medications Browse medications A–Z Every drug we’ve checked against herbs & supplements References The 1 citations behind this page Ask a pharmacist Free, personal answer from our licensed team

Still Have a Question About Mogamulizumab-kpkc and Chirata?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.